145 related articles for article (PubMed ID: 7895784)
1. Mechanistic options of erythropoietin-stimulated erythropoiesis.
Nijhof W; de Haan G; Pietens J; Dontje B
Exp Hematol; 1995 Apr; 23(4):369-75. PubMed ID: 7895784
[TBL] [Abstract][Full Text] [Related]
2. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
[TBL] [Abstract][Full Text] [Related]
3. Evidence suggesting a stimulatory role for interleukin-10 in erythropoiesis in vitro.
Wang CQ; Udupa KB; Lipschitz DA
J Cell Physiol; 1996 Feb; 166(2):305-10. PubMed ID: 8591990
[TBL] [Abstract][Full Text] [Related]
4. In vivo erythroid recovery following paclitaxel injury: correlation between GATA-1, c-MYB, NF-E2, Epo receptor expressions, and apoptosis.
Romero-Benitez MM; Aguirre MV; Juaristi JA; Alvarez MA; Trifaró JM; Brandan NC
Toxicol Appl Pharmacol; 2004 Feb; 194(3):230-8. PubMed ID: 14761679
[TBL] [Abstract][Full Text] [Related]
5. Effects of cadmium on in vitro and in vivo erythropoiesis: erythroid progenitor cells (CFU-E), iron, and erythropoietin in cadmium-induced iron deficiency anemia.
Sakata S; Iwami K; Enoki Y; Kohzuki H; Shimizu S; Matsuda M; Moriyama T
Exp Hematol; 1988 Aug; 16(7):581-7. PubMed ID: 3391251
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin responses and physical characterization of erythroid progenitor cells in Rauscher virus infected BALB/c mice.
Hasthorpe S; Bol S
J Cell Physiol; 1979 Jul; 100(1):77-86. PubMed ID: 468921
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric analysis of human bone marrow perfusion cultures: erythroid development and relationship with burst-forming units-erythroid.
Rogers CE; Bradley MS; Palsson BO; Koller MR
Exp Hematol; 1996 Apr; 24(5):597-604. PubMed ID: 8605964
[TBL] [Abstract][Full Text] [Related]
8. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
[TBL] [Abstract][Full Text] [Related]
11. Effects of human recombinant erythropoietin on differentiation and distribution of erythroid progenitor cells on murine medullary and splenic erythropoiesis during hypoxia and post-hypoxia.
Mide SM; Huygens P; Bozzini CE; Fernandez Pol JA
In Vivo; 2001; 15(2):125-32. PubMed ID: 11317516
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin-B and monensin potentiation of murine erythropoiesis in vitro: a possible role for sodium ions.
Tenaglia AN; Fry CG; Van Zant G
Exp Hematol; 1985 Jul; 13(6):512-9. PubMed ID: 3996489
[TBL] [Abstract][Full Text] [Related]
13. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
14. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ
J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861
[TBL] [Abstract][Full Text] [Related]
15. Improvement of erythroid toxicity by lentinan and erythropoietin in mice treated with chemotherapeutic agents.
Takatsuki F; Miyasaka Y; Kikuchi T; Suzuki M; Hamuro J
Exp Hematol; 1996 Feb; 24(3):416-22. PubMed ID: 8599970
[TBL] [Abstract][Full Text] [Related]
16. Erythropoiesis in vitro. IV. Effects of ouabain on erythroid stem cells (CFU-e and BFU-e).
Gallicchio VS; Murphy MJ
Stem Cells (1981); 1981; 1(1):30-7. PubMed ID: 7348866
[TBL] [Abstract][Full Text] [Related]
17. The sensitivity of in vitro erythropoietic progenitor cells to different erythropoietin reagents during development and the role of cell death in culture.
Zimmermann F; Rich IN
Exp Hematol; 1996 Feb; 24(2):330-9. PubMed ID: 8641362
[TBL] [Abstract][Full Text] [Related]
18. IL-12 directly enhances in vitro murine erythropoiesis in combination with IL-4 and stem cell factor.
Dybedal I; Larsen S; Jacobsen SE
J Immunol; 1995 May; 154(10):4950-5. PubMed ID: 7537295
[TBL] [Abstract][Full Text] [Related]
19. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide.
Malgor LA; Valsecia M; Vergés E; De Markowsky EE
Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):99-105. PubMed ID: 9695882
[TBL] [Abstract][Full Text] [Related]
20. In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO).
Johnson CS; Cook CA; Furmanski P
Exp Hematol; 1990 Feb; 18(2):109-13. PubMed ID: 2303102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
